Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Outlook Therapeutics
company
Funding Round
Post-IPO Equity
Money Raised
$ 42.60M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion |
|---|
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| May 26, 2020 | Post-IPO Equity | $ 27.20M | Syntone Ventures | Detail |
| Jul 27, 2015 | Series Unknown | $ 31M | Cormorant Global Healthcare Master Fund,Longwood Capital Partners,etc. | Detail |
| Nov 5, 2018 | Post-IPO Equity | $ 20M | Biolexis | Detail |
| Jan 29, 2021 | Post-IPO Equity | $ 35M | Detail | |
| Sep 29, 2015 | Series Unknown | 0 | Cormorant Global Healthcare Master Fund,Longwood Capital Partners,etc. | Detail |
| Feb 24, 2020 | Post-IPO Equity | $ 10.20M | Detail | |
| May 14, 2018 | Post-IPO Equity | $ 15M | GMS Tenshi Holdings | Detail |
| May 13, 2016 | IPO | $ 35M | Detail |
